Autism Risk May Rise With In Utero Exposure to Antiseizure Meds
By Elana Gotkine HealthDay Reporter
WEDNESDAY, March 20, 2024 -- The incidence of autism spectrum disorder is higher among children exposed to topiramate in the second half of pregnancy compared with the general population of children without exposure to antiseizure medications in utero, according to a study published in the March 21 issue of the New England Journal of Medicine.
Sonia Hernández‑Díaz, M.D., Dr.P.H., from the Harvard T.H. Chan School of Public Health in Boston, and colleagues identified a population-based cohort of pregnant women and their children within two health care utilization databases. Exposure to specific antiseizure medications was defined based on prescription fills from gestational week 19 until delivery.
The researchers found that at 8 years of age, the estimated cumulative incidence of autism spectrum disorder was 1.9 percent for the 4,199,796 children who had not been exposed to antiseizure medications. On restriction to children born to mothers with epilepsy, the incidence was 4.2, 6.2, 10.5, and 4.1 percent with no exposure to antiseizure medications, exposure to topiramate, exposure to valproate, and exposure to lamotrigine, respectively. Compared with no exposure to antiseizure medications, propensity score-adjusted hazard ratios were 0.96 (95 percent confidence interval, 0.56 to 1.65), 2.67 (95 percent confidence interval, 1.69 to 4.20), and 1.00 (95 percent confidence interval, 0.69 to 1.46) for exposure to topiramate, valproate, and lamotrigine, respectively.
"After adjustment for indication, the association was substantially attenuated for topiramate and lamotrigine, whereas a dose-dependent increased risk remained for valproate," the authors write.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted March 2024
Read this next
Prenatal Opioid Exposure Not Tied to Neuropsychiatric Disorders in Offspring
THURSDAY, April 25, 2024 -- Prenatal opioid exposure seems not to be associated with a meaningful increase in the risk for neuropsychiatric disorders in offspring, according to a...
Dialectical Behavior Therapy Reduces Suicidal Behavior in Adults With Autism
MONDAY, April 22, 2024 -- Dialectical behavior therapy (DBT) is safe and shows short-term efficacy in reducing suicidal ideation and suicide attempts in adults with suicidal...
Heritability for Autism Spectrum Disorder Varies for Males and Females
WEDNESDAY, April 17, 2024 -- Heritability for autism spectrum disorder (ASD) varies for males and females, with higher heritability seen for males than females, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.